Skip to content

Florian Heidel

  • M.D.
  • Staff Physician, Attending in Hematology & Medical Oncology
  • Otto-von-Guericke-University
  • 15PublicationsNumber of items in Florian's My Publications folder on Mendeley.
  • 5Followers

Research interests

LeukemiaSignalingStem Cell Biology

Followers (5)

Publications (5)

  • 3,4-Diarylmaleimides-a novel class of kinase inhibitors-effectively induce apoptosis in FLT3-ITD-dependent cells.

    • Heidel F
    • Mack T
    • Razumovskaya E
    • et al.
    N/AReaders
    N/ACitations
  • Self-renewal related signaling in myeloid leukemia stem cells

    • Heidel F
    • Mar B
    • Armstrong S
    N/AReaders
    N/ACitations
  • Severe paraneoplastic pemphigus in a patient with follicular lymphoma.

    • Krogel C
    • Fischer T
    • Heidel F
    N/AReaders
    N/ACitations
    Get full text
  • Novel pathway in Bcr-Abl signal transduction involves Akt-independent , PLC-c1-driven activation of mTOR / p70S6-kinase pathway

    • Markova B
    • Albers C
    • Breitenbuecher F
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemia.

    • Kasper S
    • Breitenbuecher F
    • Hoehn Y
    • et al.
    N/AReaders
    N/ACitations
    Get full text

Professional experience

Staff Physician, Attending in Hematology & Medical Oncology

Otto-von-Guericke-University

December 2008 - Present

Post-Doctoral Fellow

Dana-Farber Cancer Institute, Harvard University

June 2009 - July 2011(2 years)

Education history

Fellowship in Hematology/Oncology

Otto-von-Guericke University

July 2008 - December 2008(5 months)

Residency Internal Medicine, Fellowship Hematology/Oncology

Johannes-Gutenberg-Universität, Department of Hematology/Oncology/Pneumology

December 2002 - June 2008(6 years)

M.D.

Friedrich-Alexander Universität Erlangen-Nürnberg

October 1996 - October 2002(6 years)